Mon, Dec 22, 2014, 8:50 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Biogen Idec Inc. Message Board

  • me527@ymail.com me527 Mar 28, 2013 8:32 PM Flag

    BG-12

    My wife has MS. So i am very aware of the costs and different therapies and their pros and cons. BG-12 is the most talked about therapy for MS patients. The shots hurt and are not as effective as BG-12. I attended a rebif sponsered dinner last month and the hottest and most talked about topic was BG-12. Patients want it badly. This drug will dominate the market like no other oral medication. Gelenia takes a ton of testing to get on and if you have to come off of it for any reason you have to begin the testing on it all over again. Real pain in the #$%$ BG-12 will dominate all MS meds in the next few years.

 
BIIB
352.29-8.38(-2.32%)Dec 22 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Gilead Sciences Inc.
NASDAQMon, Dec 22, 2014 4:00 PM EST
Henry Schein, Inc.
NASDAQMon, Dec 22, 2014 4:00 PM EST
Rite Aid Corporation
NYSEMon, Dec 22, 2014 4:01 PM EST